8 Fetal Alcohol Spectrum Disorder: Embryogenesis Under …
217
Di Renzo F, Broccia ML, Giavini E, Menegola E (2007) Citral, an inhibitor of retinoic acid
synthesis, attenuates the frequency and severity of branchial arch abnormalities induced by
triazole-derivative fluconazole in rat embryos cultured in vitro. Reprod Toxicol 24:326–332
Dobbs-McAuliffe B, Zhao Q, Linney E (2004) Feedback mechanisms regulate retinoic acid
production and degradation in the zebrafish embryo. Mech Dev 121:339–350
Driscoll DA, Salvin J, Sellinger B, Budarf ML, McDonald-McGinn DM, Zackai EH, Emanuel
BS (1993) Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes:
implications for genetic counselling and prenatal diagnosis. J Med Genet 30:813–817
Duester G (1991) A hypothetical mechanism for fetal alcohol syndrome involving ethanol inhibition
of retinoic acid synthesis at the alcohol dehydrogenase step. Alcohol Clin Exp Res 15:568–572
Dupé V, Matt N, Garnier J-M, Chambon P, Mark M, Ghyselinck NB (2003) A newborn lethal defect
due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid
treatment. Proc Natl Acad Sci USA 100:14036–14041
Durston AJ, Timmermans JP, Hage WJ, Hendriks HF, de Vries NJ, Heideveld M, Nieuwkoop PD
(1989) Retinoic acid causes an anteroposterior transformation in the developing central nervous
system. Nature 340:140–144
Eberhart JK, Parnell SE (2016) The genetics of fetal alcohol spectrum disorders. Alcohol Clin Exp
Res 40:1154–1165
Edenberg HJ, Foroud T (2013) Genetics and alcoholism. Nat Rev. Gastroenterol Hepatol 10:487–
494
Edenberg HJ, McClintick JN (2018) Alcohol dehydrogenases, aldehyde dehydrogenases and alcohol
use disorders: a critical review. Alcohol Clin Exp Res 42:2281–2297
Ehrhart F, Roozen S, Verbeek J, Koek G, Kok G, van Kranen H, Evelo CT et al (2019) Review and
gap analysis: molecular pathways leading to fetal alcohol spectrum disorders. Mol Psychiatry
24:10–17
Elsea SH, Williams SR (2011) Smith-Magenis syndrome: haploinsufficiency of RAI1 results in
altered gene regulation in neurological and metabolic pathways. Exp Rev Mol Med 13:e14
Fainsod A, Kot-Leibovich H (2018) Xenopus embryos to study fetal alcohol syndrome, a model
for environmental teratogenesis. Biochem Cell Biol (Biochim et Biol Cell) 96:77–87
Feng W, Shao C, Liu H-K (2017) Versatile Roles of the Chromatin Remodeler CHD7 during Brain
Development and Disease. Front Mol Neurosci 10:309
Féré CH (1895) Etudes experimentales sur l’influence teratogene ou degenerative des alcools et des
essences sur l’embryon de poulet. J de IAnatomie et de la Physiol 31:161–186
Fernandes Y, Buckley DM, Eberhart JK (2018) Diving into the world of alcohol teratogenesis: a
review of zebrafish models of fetal alcohol spectrum disorder. Biochem Cell Biol (Biochim et
Biol Cell) 96:88–97
Flentke GR, Smith SM (2018) The avian embryo as a model for fetal alcohol spectrum disorder.
Biochem Cell Biol (Biochim et Biol Cell) 96:98–106
Fransén K, Franzén P, Magnuson A, Elmabsout AA, Nyhlin N, Wickbom A, Curman B et al
(2013) Polymorphism in the retinoic acid metabolizing enzyme CYP26B1 and the development
of Crohn’s disease. PLoS ONE 8:e72739
Gavrilova R, Babovic N, Lteif A, Eidem B, Kirmani S, Olson T, Babovic-Vuksanovic D (2009)
Vitamin A deficiency in an infant with PAGOD syndrome. Am J Med Genet Part A 149A:2241–
2247
Ghyselinck NB, Duester G (2019) Retinoic acid signaling pathways. Development 146
Gilbert-Barness E (2010) Teratogenic causes of malformations. Ann Clin Lab Sci 40:99–114
Girirajan S, Truong HT, Blanchard CL, Elsea SH (2009) A functional network module for SmithMagenis syndrome. Clin Genet 75:364–374
Golzio C, Martinovic-Bouriel J, Thomas S, Mougou-Zrelli S, Grattagliano-Bessieres B, Bonniere
M, Delahaye S et al (2007) Matthew-Wood syndrome is caused by truncating mutations in the
retinol-binding protein receptor gene STRA6. Am J Hum Genet 80:1179–1187
González ER (1979) Skeletal defects and fetal alcohol syndrome. Arch Intern Med 959
Goyal MM, Basak A (2010) Human catalase: looking for complete identity. Protein Cell 1:888–897
217
Di Renzo F, Broccia ML, Giavini E, Menegola E (2007) Citral, an inhibitor of retinoic acid
synthesis, attenuates the frequency and severity of branchial arch abnormalities induced by
triazole-derivative fluconazole in rat embryos cultured in vitro. Reprod Toxicol 24:326–332
Dobbs-McAuliffe B, Zhao Q, Linney E (2004) Feedback mechanisms regulate retinoic acid
production and degradation in the zebrafish embryo. Mech Dev 121:339–350
Driscoll DA, Salvin J, Sellinger B, Budarf ML, McDonald-McGinn DM, Zackai EH, Emanuel
BS (1993) Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes:
implications for genetic counselling and prenatal diagnosis. J Med Genet 30:813–817
Duester G (1991) A hypothetical mechanism for fetal alcohol syndrome involving ethanol inhibition
of retinoic acid synthesis at the alcohol dehydrogenase step. Alcohol Clin Exp Res 15:568–572
Dupé V, Matt N, Garnier J-M, Chambon P, Mark M, Ghyselinck NB (2003) A newborn lethal defect
due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid
treatment. Proc Natl Acad Sci USA 100:14036–14041
Durston AJ, Timmermans JP, Hage WJ, Hendriks HF, de Vries NJ, Heideveld M, Nieuwkoop PD
(1989) Retinoic acid causes an anteroposterior transformation in the developing central nervous
system. Nature 340:140–144
Eberhart JK, Parnell SE (2016) The genetics of fetal alcohol spectrum disorders. Alcohol Clin Exp
Res 40:1154–1165
Edenberg HJ, Foroud T (2013) Genetics and alcoholism. Nat Rev. Gastroenterol Hepatol 10:487–
494
Edenberg HJ, McClintick JN (2018) Alcohol dehydrogenases, aldehyde dehydrogenases and alcohol
use disorders: a critical review. Alcohol Clin Exp Res 42:2281–2297
Ehrhart F, Roozen S, Verbeek J, Koek G, Kok G, van Kranen H, Evelo CT et al (2019) Review and
gap analysis: molecular pathways leading to fetal alcohol spectrum disorders. Mol Psychiatry
24:10–17
Elsea SH, Williams SR (2011) Smith-Magenis syndrome: haploinsufficiency of RAI1 results in
altered gene regulation in neurological and metabolic pathways. Exp Rev Mol Med 13:e14
Fainsod A, Kot-Leibovich H (2018) Xenopus embryos to study fetal alcohol syndrome, a model
for environmental teratogenesis. Biochem Cell Biol (Biochim et Biol Cell) 96:77–87
Feng W, Shao C, Liu H-K (2017) Versatile Roles of the Chromatin Remodeler CHD7 during Brain
Development and Disease. Front Mol Neurosci 10:309
Féré CH (1895) Etudes experimentales sur l’influence teratogene ou degenerative des alcools et des
essences sur l’embryon de poulet. J de IAnatomie et de la Physiol 31:161–186
Fernandes Y, Buckley DM, Eberhart JK (2018) Diving into the world of alcohol teratogenesis: a
review of zebrafish models of fetal alcohol spectrum disorder. Biochem Cell Biol (Biochim et
Biol Cell) 96:88–97
Flentke GR, Smith SM (2018) The avian embryo as a model for fetal alcohol spectrum disorder.
Biochem Cell Biol (Biochim et Biol Cell) 96:98–106
Fransén K, Franzén P, Magnuson A, Elmabsout AA, Nyhlin N, Wickbom A, Curman B et al
(2013) Polymorphism in the retinoic acid metabolizing enzyme CYP26B1 and the development
of Crohn’s disease. PLoS ONE 8:e72739
Gavrilova R, Babovic N, Lteif A, Eidem B, Kirmani S, Olson T, Babovic-Vuksanovic D (2009)
Vitamin A deficiency in an infant with PAGOD syndrome. Am J Med Genet Part A 149A:2241–
2247
Ghyselinck NB, Duester G (2019) Retinoic acid signaling pathways. Development 146
Gilbert-Barness E (2010) Teratogenic causes of malformations. Ann Clin Lab Sci 40:99–114
Girirajan S, Truong HT, Blanchard CL, Elsea SH (2009) A functional network module for SmithMagenis syndrome. Clin Genet 75:364–374
Golzio C, Martinovic-Bouriel J, Thomas S, Mougou-Zrelli S, Grattagliano-Bessieres B, Bonniere
M, Delahaye S et al (2007) Matthew-Wood syndrome is caused by truncating mutations in the
retinol-binding protein receptor gene STRA6. Am J Hum Genet 80:1179–1187
González ER (1979) Skeletal defects and fetal alcohol syndrome. Arch Intern Med 959
Goyal MM, Basak A (2010) Human catalase: looking for complete identity. Protein Cell 1:888–897